A new trading day began on Friday, with Vir Biotechnology Inc (NASDAQ: VIR) stock price down -5.34% from the previous day of trading, before settling in for the closing price of $9.73. VIR’s price has ranged from $7.61 to $14.27 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 421.39%. Meanwhile, its annual earnings per share averaged 26.22%. With a float of $89.63 million, this company’s outstanding shares have now reached $134.78 million.
Let’s determine the extent of company efficiency that accounts for 587 employees.
Vir Biotechnology Inc (VIR) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vir Biotechnology Inc is 34.40%, while institutional ownership is 52.79%. The most recent insider transaction that took place on Jun 11 ’24, was worth 43,789. In this transaction Director of this company sold 4,000 shares at a rate of $10.95, taking the stock ownership to the 14,619 shares. Before that another transaction happened on Apr 03 ’24, when Company’s Chief Executive Officer sold 72,995 for $9.46, making the entire transaction worth $690,365. This insider now owns 678,457 shares in total.
Vir Biotechnology Inc (VIR) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 26.22% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.00% during the next five years compared to -34.12% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Here are Vir Biotechnology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.58, a number that is poised to hit -1.05 in the next quarter and is forecasted to reach -3.72 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Looking closely at Vir Biotechnology Inc (NASDAQ: VIR), its last 5-days average volume was 0.88 million, which is a drop from its year-to-date volume of 1.08 million. As of the previous 9 days, the stock’s Stochastic %D was 17.70%. Additionally, its Average True Range was 0.53.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 29.20%, which indicates a significant increase from 9.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.86% in the past 14 days, which was lower than the 63.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.92, while its 200-day Moving Average is $9.68. However, in the short run, Vir Biotechnology Inc’s stock first resistance to watch stands at $9.43. Second resistance stands at $9.64. The third major resistance level sits at $9.85. If the price goes on to break the first support level at $9.01, it is likely to go to the next support level at $8.80. Should the price break the second support level, the third support level stands at $8.59.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
With a market capitalization of 1.26 billion, the company has a total of 136,059K Shares Outstanding. Currently, annual sales are 86,180 K while annual income is -615,060 K. The company’s previous quarter sales were 56,380 K while its latest quarter income was -65,280 K.
